BINOCULAR IMPLANTATION OF NEW DIFFRACTIVE TRIFOCAL INTRAOCULAR LENS FOR PRESBYOPIA CORRECTION

Aim. Evaluation of the visual and functional results of bilateral implantation of the diffractive trifocal intraocular lens (IOL), the incidence of adverse optical phenomena and the degree of patient satisfaction. Methods. A prospective, open-label study included 82 patients (164 eyes) with presbyopia who underwent cataract phacoemulsification (n = 128) or refractive lensectomy (n = 36) with bilateral implantation of a new multifocal IOL AT LISA tri 839MP. The mean age of the patients was 61.2 ± 11.8 (32-84) years. The period of observation of patients was from 6 to 36 (18.3 ± 3.9) months. Results. After 1 year of follow-up, the increase in UCNVA was observed from 0.19 ± 0.17 to 0.89 ± 0.21, UCIVA from 0.18 ± 0.20 to 0.78 ± 0.17, UCDVA from 0.26 ± 0, 23 to 0.9 ± 0.12 (p

Download Full-text

The Effect of Fenoprofen Calcium (Nalfon) on Levels of Rheumatoid Factor in Patients with Rheumatoid Arthritis

Journal of International Medical Research ◽

10.1177/030006057300100205 ◽

1973 ◽

Vol 1 (2) ◽

pp. 412-416

Author(s):

Joan E Himes ◽

Ivan F Duff

Keyword(s):

Rheumatoid Arthritis ◽

Rheumatoid Factor ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

The Mean ◽

Baseline Levels ◽

One Year

In 88.9% of a group of 18 patients with rheumatoid arthritis participating in an open-label study with fenoprofen calcium (Nalfon), there was observed a mean litre decrease in level of rheumatoid factor as compared to baseline levels. In follow-up, three months to one year later, a uniform litre increase above the mean level of the study period had occurred. In all cases the titre returned to baseline levels or higher.

Download Full-text

Bortezomib, thalidomide, and dexamethasone followed by double autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GIMEMA-MMY-3006): long-term follow-up analysis of a randomised phase 3, open-label study

The Lancet Haematology ◽

10.1016/s2352-3026(20)30323-9 ◽

2020 ◽

Vol 7 (12) ◽

pp. e861-e873 ◽

Cited By ~ 1

Author(s):

Paola Tacchetti ◽

Lucia Pantani ◽

Francesca Patriarca ◽

Maria Teresa Petrucci ◽

Elena Zamagni ◽

...

Keyword(s):

Haematopoietic Stem Cell Transplantation ◽

Haematopoietic Stem Cell ◽

Newly Diagnosed ◽

Open Label ◽

Phase 3 ◽

Open Label Study ◽

Label Study ◽

Long Term Follow Up

Download Full-text

Long-term follow-up of DYT1 dystonia patients treated by deep brain stimulation: An open-label study

Movement Disorders ◽

10.1002/mds.22802 ◽

2010 ◽

Vol 25 (3) ◽

pp. 289-299 ◽

Cited By ~ 98

Author(s):

Laura Cif ◽

Xavier Vasques ◽

Victoria Gonzalez ◽

Patrice Ravel ◽

Brigitte Biolsi ◽

...

Keyword(s):

Deep Brain Stimulation ◽

Brain Stimulation ◽

Open Label ◽

Open Label Study ◽

Label Study ◽

Dyt1 Dystonia ◽

Long Term Follow Up ◽

Deep Brain

Download Full-text

A prospective, randomized, open-label study of steroid withdrawal in pancreas transplantation—a preliminary report with 6-month follow-up

Transplantation Proceedings ◽

10.1016/s0041-1345(00)02632-4 ◽

2001 ◽

Vol 33 (1-2) ◽

pp. 1663-1664 ◽

Cited By ~ 34

Author(s):

R.W.G Gruessner ◽

D.E.R Sutherland ◽

E Parr ◽

A Humar ◽

A.C Gruessner

Keyword(s):

Pancreas Transplantation ◽

Preliminary Report ◽

Steroid Withdrawal ◽

Open Label ◽

Open Label Study ◽

Label Study

Download Full-text

A Randomized, Open-Label Study to Assess Efficacy of Weekly Assumption of Cholecalciferol Versus Calcifediol in Older Patients With Hypovitaminosis D

10.20944/preprints202111.0009.v1 ◽

2021 ◽

Author(s):

Chukwuma Okoye ◽

Valeria Calsolaro ◽

Filippo Niccolai ◽

Alessia Maria Calabrese ◽

Riccardo Franchi ◽

...

Keyword(s):

Vitamin D ◽

Vitamin D3 ◽

Older Patients ◽

Randomized Study ◽

Hypovitaminosis D ◽

Clinical History ◽

Open Label ◽

Open Label Study ◽

The Mean

The aim of this single-center, open-label, non-controlled randomized study was to evaluate which formulation of vitamin D between cholecalciferol and calcifediol is most effective in the treatment of hypovitaminosis D in older adults. Demographic characteristics, clinical history and comprehensive geriatric assessment were recorded at admission. Eligible patients randomly received an equivalent vitamin D supplement either with cholecalciferol or calcifediol from hospital admission to three months after discharge. Among the 140 older patients included (mean age 83±6.6, 57.8% females), 69 received cholecalciferol and 71 calcifediol. The mean plasma values of 25OH-Vitamin D3 found at the enrollment were 16.8 ± 9.9 ng/mL in patients receiving cholecalciferol and 18.8 ± 13.3 ng/mL in those treated with calcifediol (p =0.31). At the 3-month follow up, the mean concentration of 25OH-Vitamin D3 was significantly higher in patients treated with calcifediol than in patients treated with cholecalciferol (respectively, 30.7 ± 8.4 vs 45.4 ± 9.8 ng/mL, p &lt;0.001). Supplementation with cholecalciferol or calcifediol results in both cases effective in reaching optimal circulating values of 25OH-VitaminD3 in the older patients suffering from hypovitaminosis D. However, supplementation with calcifediol led to average circulating values of 25OH- VitaminD3 significantly higher (over 50%) than those obtained with cholecalciferol.

Download Full-text